STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more

AI justification

Lilly's coercive threat undermines healthcare access for vulnerable populations. | Lilly's action pressures hospitals to comply with data submission, which may enhance transparency but risks undermining the 340B program's core mission of providing affordable drugs to vulnerable populations. The coercive nature of the threat disproportionately impacts safety-net hospitals serving low-income patients.